In vitro antimicrobial inhibition patterns of nutritionally variant streptococci.

Antimicrobial Agents and Chemotherapy
R C Cooksey, J M Swenson

Abstract

Twenty-four isolates of nutritionally variant streptococci, previously categorized as species included among the viridans streptococci, were tested for susceptibility to 12 antimicrobial agents. Minimum inhibitory concentrations for these isolates and for a control group of viridans streptococci with no apparent nutritional deficiencies were determined in two microdilution systems. Pyridoxal hydrochloride, which enhances growth of the nutritional variants, was added to one of these microdilution systems but not to the other. An agar dilution method was also used to test the nutritionally variant isolates. Minimum inhibitory concentrations determined by the three methods compared favorably. Penicillin, nafcillin, methicillin, and clindamycin were less effective in vitro against the nutritional variants than were the other antibiotics tested. Streptomycin, however, was less effective against the control isolates.

References

Apr 27, 1979·JAMA : the Journal of the American Medical Association·L Resnick, L Cohen
Sep 1, 1979·Journal of Clinical Microbiology·R C CookseyR R Facklam
Jun 1, 1975·The Journal of Applied Bacteriology·M SukchotiratanaJ P Fletcher
Aug 1, 1977·Annals of Internal Medicine·R B CareyR B Roberts
Feb 1, 1974·Journal of Medical Microbiology·R H George
May 1, 1974·American Journal of Clinical Pathology·L R McCarthy, E J Bottone
May 1, 1974·The Journal of Infectious Diseases·M A Sande, R G Irvin
Nov 1, 1970·Annals of Internal Medicine·W H SpencerN K Wenger

❮ Previous
Next ❯

Citations

Dec 1, 1983·Diagnostic Microbiology and Infectious Disease·L G Reimer, L B Reller
Mar 1, 1988·Diagnostic Microbiology and Infectious Disease·C ThornsberryB C Hill
Dec 8, 2000·Diagnostic Microbiology and Infectious Disease·M J TuohyJ A Washington
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C K MurrayJ H Jorgensen
Mar 1, 1990·Equine Veterinary Journal·D V HackerH Scagliotti
Feb 1, 1993·Diagnostic Microbiology and Infectious Disease·Y Omran, C A Wood
Aug 14, 1999·Scandinavian Journal of Infectious Diseases·J J ChristensenR R Facklam
Mar 1, 1985·Mayo Clinic Proceedings·J A Washington, W R Wilson
Jan 13, 2017·Journal of Clinical Microbiology·Kunatum Prasidthrathsint, Mark A Fisher
Sep 19, 2002·The Pediatric Infectious Disease Journal·Hsiu-Hao ChangLi-Min Huang
Dec 1, 1984·Journal of Clinical Microbiology·R HigginsS S Jang
Apr 1, 1991·Clinical Microbiology Reviews·K L Ruoff
Apr 16, 1999·Journal of Clinical Microbiology·H NamdariD J Savage
Sep 1, 1994·Journal of Clinical Microbiology·C P DouglasT Gottlieb

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.